These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6478832)

  • 1. PID associated with fertility regulating agents. Task Force on Intrauterine Devices, Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization.
    Contraception; 1984 Jul; 30(1):1-21. PubMed ID: 6478832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational case-control study of ectopic pregnancy. The World Health Organization's Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.
    Clin Reprod Fertil; 1985 Jun; 3(2):131-43. PubMed ID: 4052920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
    Senanayake P; Kramer DG
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors.
    Eschenbach DA; Harnisch JP; Holmes KK
    Am J Obstet Gynecol; 1977 Aug; 128(8):838-50. PubMed ID: 407795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic inflammatory disease with intrauterine device use: a reassessment.
    Kessel E
    Fertil Steril; 1989 Jan; 51(1):1-11. PubMed ID: 2642807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IUD users may have higher risk of contracting PID, studies find; pill may have protective effect.
    Fam Plann Perspect; 1980; 12(4):206-8. PubMed ID: 7439343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
    O'Brien FB; Stewart WC; Sturtevant FM
    Contraception; 1983 Feb; 27(2):111-22. PubMed ID: 6851553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IUDs and PID: understanding the American situation.
    Netw Res Triangle Park N C; 1987; 8(2):8. PubMed ID: 12268660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.
    Steenland MW; Zapata LB; Brahmi D; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):611-24. PubMed ID: 23177264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine device and pelvic inflammatory disease.
    Thaler I; Paldi E; Steiner D
    Int J Fertil; 1978; 23(1):69-72. PubMed ID: 30713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper IUDs, PID, and fertility in nulliparous women.
    Struthers BJ
    Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive practice before and after therapeutic abortion. II. Use-effectiveness of oral contraceptives and intrauterine devices.
    Fylling P; Svendsby T
    Fertil Steril; 1979 Jul; 32(1):24-7. PubMed ID: 456627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study.
    Rookus MA; van Leeuwen FE
    J Natl Cancer Inst; 1996 Dec; 88(23):1759-64. PubMed ID: 8944006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.